Correlation Between NISOURCE and Bristol Myers

Can any of the company-specific risk be diversified away by investing in both NISOURCE and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NISOURCE and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NISOURCE INC and Bristol Myers Squibb, you can compare the effects of market volatilities on NISOURCE and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NISOURCE with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of NISOURCE and Bristol Myers.

Diversification Opportunities for NISOURCE and Bristol Myers

-0.37

Correlation Coefficient

NISOURCE  Bristol Myers

Very good diversification

The 3 months correlation between NISOURCE and Bristol is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding NISOURCE INC and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and NISOURCE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NISOURCE INC are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of NISOURCE i.e., NISOURCE and Bristol Myers go up and down completely randomly.

Pair Corralation between NISOURCE and Bristol Myers

Assuming the 90 days trading horizon NISOURCE INC is expected to under-perform the Bristol Myers. But the bond apears to be less risky and, when comparing its historical volatility, NISOURCE INC is 1.12 times less risky than Bristol Myers. The bond trades about -0.27 of its potential returns per unit of risk. The Bristol Myers Squibb is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  95,555  in Bristol Myers Squibb on October 12, 2024 and sell it today you would earn a total of  4,334  from holding Bristol Myers Squibb or generate 4.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	90.48%
Values	Daily Returns

NISOURCE INC  vs.  Bristol Myers Squibb

NISOURCE INC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NISOURCE INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for NISOURCE INC investors.

Bristol Myers Squibb

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol Myers reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NISOURCE and Bristol Myers

The main advantage of trading using opposite NISOURCE and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NISOURCE position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.

The idea behind NISOURCE INC and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.